Galanthamine-O-methyl-d3 Hydrobromide
| Product Name |
Galanthamine-O-methyl-d3 Hydrobromide
|
| Product Code |
DA-G007-t
|
| Chemical name |
Galanthamine-O-methyl-d3 Hydrobromide
|
| Synonyms |
(4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-d3-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide; Galanthamine-d3 Hydrobromide; (-)-Galantamine-d3 Hydrobromide; (-)-Galanthamine-d3 Hydrobromide; Galantamine-d3 Hydrobromide; Galanthamine-d3 Hydrogen Bromide; Jilkon-d3 Hydrobromide; Lycoremine-d3 Hydrobromide; Nivalin-d3; Nivaline-d3; Nivaline-d3 (pharmaceutical); Razadyne-d3; Reminyl-d3; Tamilin-d3; (4aS,6R,8aS)-3-Methoxy-d3-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol Hydrobromide
|
| Impurity |
NA
|
| CAS Number |
NA
|
| Alternate CAS # |
NA
|
| Molecular form |
C17H19D3BrNO3
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
371.28
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
aromatics,chiral standards,heterocycles,pharmaceutical standards,intermediates,fine chemicals,stable isotopes
|
| Boiling Point |
NA
|
| Applications |
Galanthamine-O-methyl-d3 Hydrobromide is the labeled analogue of Galanthamine Hydrobromide, a selective acetylcholinesterase inhibitor. A therapeutic agent for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
